XIGDUO XR (DAPAGLIFLOZIN/METFORMIN HCL)

Xigduo XR (extended release) is prescribed for treating people with type 2 diabetes. The active ingredients are Dapagliflozin; an SGLT2 inhibitor, and Metformin Hydrochloride; a biguanide drug. Together, Dapagliflozin works by blocking the reabsorption of glucose in your kidneys, increases the excretion of glucose, thereby lowering the glucose levels in your blood. Metformin HCl acts on your liver by decreasing the amount of glucose (sugar) it produces, lowers the amount of sugar your body absorbs from your diet, and increases insulin receptor sensitivity to improve how your body responds to your own insulin. Xigduo XR is not for treating type1 diabetes as it needs to work with the insulin you are still producing.